Finally, the limited effects of variants like Clasp2*L163P suggest that the specific variant is not disease‐associated, its AD‐related effects are not visible in the transcriptome, and/or it does not trigger changes until later age. This evidence concerns the gene CLASP2 and Alzheimer disease.